SeaStar Medical Holding Corp
For the period ended Dec 31, 2023. Filed Apr 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 16, 2024
ICU$1.96+4.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
As of December 31, 2023 and 2022
| 2023 · 2022 | ||||
|---|---|---|---|---|
| (As Restated) | ||||
| ASSETS | ||||
| Current assets | ||||
| Cash | $ | 176 | $ | 47 |
| Other receivables | — | 12 | ||
| Prepaid expenses | 2,132 | 1,460 | ||
| Total current assets | 2,308 | 1,519 | ||
| Other assets | 1,205 | 1,519 | ||
| Total assets | $ | 3,513 | $ | 3,038 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||
| Current liabilities | ||||
| Accounts payable | $ | 4,372 | $ | 1,927 |
| Accrued expenses | 1,523 | 2,245 | ||
| Contingent upfront payment for license agreement | 100 | — | ||
| Notes payable, net of deferred financing costs | 565 | 1,178 | ||
| Convertible notes, current portion | 4,179 | — | ||
| Forward purchase agreement derivative liability | — | 10,211 | ||
| Liability classified warrants | 2,307 | 587 | ||
| Total current liabilities | 13,046 | 16,148 | ||
| Notes payable, net of deferred financing costs | 4,143 | 7,652 | ||
| Convertible notes, net of current portion | 194 | — | ||
| Total liabilities | 17,383 | 23,800 | ||
| Commitments and contingencies (Note 14) | ||||
| Stockholders' deficit | ||||
| Preferred stock - $0.0001 par value, 10,000,000 and 10,000,000 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022, respectively. | — | — | ||
| Common stock - $0.0001 par value per share; 500,000,000 and 100,000,000 shares authorized at December 31, 2023 and 2022, respectively; 47,615,285 and 12,699,668 shares issued and outstanding at December 31, 2023 and 2022, respectively | 5 | 1 | ||
| Additional paid-in capital | 100,859 | 67,739 | ||
| Accumulated deficit | (114,734) | (88,502) | ||
| Total stockholders' deficit | (13,870) | (20,762) | ||
| Total liabilities and stockholders' deficit | $ | 3,513 | $ | 3,038 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.